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Background/aim: We aimed to investigate the associations between the radiographic phenotypes and the presence of metabolic
syndrome (MetS) in patients with knee osteoarthritis (OA).
Materials and methods: We evaluated women age 40 and over who presented to our outpatient clinics with knee pain and fulfilled
the clinical and radiographic criteria for the classification of idiopathic OA of the knee. Patients were categorized into two groups
concerning dominant radiographic phenotype. We included consecutive 50 patients in each group. All patients were evaluated in terms
of MetS according to the revised diagnostic criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP
ATP III), as well as the World Health Organization (WHO).
Results: Overall, MetS prevalence was found to be 79% according to the NCEP ATP III-MetS criteria and 65% according to the WHOMetS criteria. Prevalence of MetS was higher in the joint space narrowing (JSN)-dominant group compared to the osteophyte (O)dominant knee OA group, but the difference did not reach statistical significance. However, in subgroup analysis (54 patients) in which
we excluded patients with a past medical history of type 2 diabetes mellitus (DM), the prevalence of NCEP ATP III-MetS was statistically
significantly higher in the JSN-dominant group compared to the O-dominant group [22 (75.9%) vs. 12 (48%), respectively, p = 0.03].
Logistic regression analysis in the subgroup demonstrated that the presence of NCEP ATP III-MetS was an independent risk factor for
JSN-dominant knee OA phenotype [OR and 95% CI = 3.48 (1.09–11.13)].
Conclusion: The prevalence of MetS is quite high in patients with knee OA and is particularly pronounced in patients with JSNdominant radiographic phenotype. Moreover, our results suggest that MetS is an independent risk factor for JSN-dominant knee OA in
patients with no past medical history of DM.
Key words: Osteoarthritis, knee, metabolic syndrome

1. Introduction
Osteoarthritis (OA) is a chronic articular disease involving
both cartilage degeneration and bony changes. It is
thought that the pathogenesis of the disease consists of
variable degrees of mechanical factors and inflammatory
mechanisms, which might be triggered by metabolic
factors and tissue destruction end products. Several factors,
including obesity, associated with disease pathogenesis and
progression have been investigated which. It is believed
that obesity affects disease occurrence and progression
with two distinct mechanisms. One of them is articular

degeneration arising from mechanical overload and the
other is systemic and local inflammation related to obesity
[1,2].
Metabolic syndrome (MetS) is a clinical picture that
includes at least 3 of these conditions: central obesity,
dyslipidemia, hypertension, diabetes mellitus (DM), or
hyperglycemia [3,4]. The intersection of MetS and OA is the
production of inflammatory cytokines related to obesity
and originating from adipose tissue. Several inflammatory
pathways which are involved in the pathogenesis of MetS
are also responsible for the pathogenesis of OA. Many
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studies have examined the prevalence of MetS in the
population with knee OA or have attempted to examine the
relationship between MetS and knee OA [5,6]. However,
none of these studies investigated the effect of MetS on
the radiographic phenotype of OA. We have previously
studied radiographic phenotypes of obese patients with
knee OA and demonstrated that the association between
obesity and osteophyte formation was stronger than that of
joint space narrowing (JSN) [7]. The present study aimed
to investigate the associations between the radiographic
phenotypes and MetS in patients with knee OA.
2. Materials and methods
In our study, female patients 40 years and older who
presented with knee pain to the rheumatology and/
or orthopedics outpatient clinics in Health Sciences
University, Samsun Research and Training Center
and fulfilled the 1986 ACR “clinical and radiographic
OA” classification criteria of knee OA were included
[8]. The knee radiographs were evaluated by a single
rheumatology specialist experienced in grading [7].
Osteophyte formation and JSN of each radiography were
graded according to the revised atlas of the Osteoarthritis
Research Society International (OARSI) [9]. A painful
knee was included for radiographic evaluation. When
both knees were painful, the knee with more advanced
radiographic findings was included. Detailed grading of
the knee radiographs concerning osteophytes (grade 0–3)
and JSN (grade 0–3) according to the revised OARSI atlas
were done [9]. In this grading system, osteophytes are
evaluated at 4 sites (medial femoral condyle, medial tibial
plateau, lateral femoral condyle, lateral tibial plateau)
and JSN is evaluated at 2 sites (medial and lateral). The
highest grade at any site was used for classification of the
radiographic phenotype and each subject was assigned to
one of the following 2 groups: Osteophyte (O)-dominant
(if the maximum osteophyte score is greater than the
maximum JSN score), JSN-dominant (if the maximum
JSN score is greater than the maximum osteophyte score).
Based on the prevalence of MetS in the population aged
40 and over in Turkey (54.5%) [10], the number of patients
required to be included in both groups at 80% power, 95%
confident interval, and p < 0.05 statistical significance was
calculated as 50.
The weight and height of all the patients were measured
and body mass index (BMI) was calculated [weight (kg) /
height (m2)]. In patients with no history of hypertension
blood pressure was measured. Waist circumference
and hip circumference were measured, and waist/hip
circumference ratio was calculated per patient. Venous
blood samples were obtained for fasting blood glucose,
high-density lipoprotein (HDL), triglyceride (TG) levels
following 12 hours of fasting. Albumin/ creatinine ratio
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was measured and calculated in spot urine samples. 75
gr oral glucose tolerance test was performed for patients
who had fasting blood glucose levels between 100 - 110
mg/dl. The patients were classified into 3 groups according
to the 2-hour glucose results obtained in the 75 g glucose
tolerance test according to the World Health Organization
(WHO) criteria [11]: Type 2 DM (glucose level 200 mg/
dL and above), impaired glucose tolerance (glucose
level between 140–199 mg/dL) and impaired fasting
glucose (glucose level below 140 mg /dL). Fasting insulin
and hemoglobin A1c (HbA1c) levels were obtained from
all patients, except those with a past medical history of
Type 2 DM. Homeostasis Model of Assessment (HOMA)
index was used for the diagnosis of insulin resistance
[(fasting glucose × fasting insulin) / 405]. HOMA index
greater than 2.7 was accepted as insulin resistance [12].
All patients were evaluated in terms of MetS using both
National Cholesterol Education Program Adult Treatment
Panel III (NCEP ATP III) revised by National Heart, Lung,
Blood Institute/American Heart Association and WHO
criteria [3,4]. According to the NCEP ATP III for the
diagnosis of MetS, there should be three or more of the
following five criteria: 1) abdominal obesity, given as waist
circumference (> 102 cm in men, > 88 cm in women),
2) TG ≥ 150 mg/dL, 3) HDL cholesterol ( < 40 mg/dL in
men, < 50 mg/dL in women), 4) blood pressure ≥130 / ≥ 85
mmHg, 5. fasting glucose ≥ 110 mg/dL [3]. According to
WHO for the diagnosis of MetS, there should be three or
more of the following six criteria at least being about glucose
metabolism disorder (impaired fasting glucose, impaired
glucose tolerance or DM and/or insulin resistance): 1)
impaired glucose tolerance, impaired fasting glucose or
DM, 2) insulin resistance, 3) antihypertensive medication
and/or high blood pressure (≥140 / ≥90 mmHg), 4) plasma
triglycerides ≥150 mg/dL 5) HDL cholesterol (<35 mg/dL
in men or <39 mg/dL in women), 5) BMI >30 kg/m2 and/
or waist: hip ratio >0.9 in men, >0.85 in women, 6) urinary
albumin excretion rate ≥20 μg/min or albumin: creatinine
ratio ≥30 mg/g [4].
The following patients were excluded from the study:
1. Patients who refused to be a volunteer for the study,
2. Patients with secondary knee OA,
3. Disabled patients who cannot remain in the standing
position,
4. Patients who have had an intraarticular injection
into the knee joint,
5. Patients with prior history of knee trauma,
6. Patients with prior history of knee surgery,
7. Patients with type 1 DM,
8. Patients receiving any lipid-lowering therapy,
9. Patients under glucocorticoid therapy patients with
C reactive protein levels above the upper limit of the
normal range.
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2.1. Statistical analysis
Continuous variables were expressed as mean ± standard
deviation (SD). Categorical variables were expressed
as number (%). The student’s t-test was used for the
comparisons of the continuous variables. The chi-square
test was used for the comparison of categorical variables.
Logistic regression analysis was used for assessing
independent risk factors. The enter method was used in the
logistic regression analysis, and the presence of MetS, BMI,
and age was included in the analysis as independent risk
factors. The reproducibility of the radiographic evaluations
was assessed using the weighted kappa (κ) statistics. A
p-value less than 0.05 was accepted as significant.
3. Results
3.1. Reproducibility of the radiographic evaluations
The radiographs from 50 randomly selected subjects
were regraded by the same observer one month after
the first evaluation for intra-observer variability. The
reproducibility of both osteophyte and JSN assessments
was excellent. Intra-observer reproducibility was better for
osteophyte assessments compared to JSN assessments (κ
= 0.92 for osteophyte scores and κ = 0.82 for JSN scores).
3.2. Main group analysis
We categorized patients into two groups concerning the
radiographic phenotype: O-dominant vs JSN-dominant
and included 50 patients in each group. A total of 100
patients were studied. The mean ± SD age of the study
population was 62 ± 6. Overall, MetS prevalence was
79% according to NCEP ATP III-MetS criteria and 65%
according to WHO-MetS criteria.
Age, height, weight, BMI, waist circumference, hip
circumference, waist/hip circumference ratio, fasting
blood glucose levels, HDL levels, and TG levels all
were found to be similar between JNS-dominant and
O-dominant groups (Table 1). Prevalence of NCEP ATP
III-MetS was higher in the JNS-dominant group when
compared to the O-dominant group, but this difference
was not statistically significant [42 (84%) vs. 37 (74%),
respectively and p = 0.22]. Similarly, the prevalence of
WHO-MetS was higher in the JNS-dominant group when
compared to the O-dominant group, but this difference
was also not statistically significant [34 (68%) vs 31 (62%),
respectively and p = 0.53).
3.3. Subgroup analysis
A subgroup was created to exclude patients who were
previously diagnosed with type 2 DM and were already
on treatment. Patients who were newly diagnosed with
type 2 DM per results of the above-described study
parameters were not excluded since they had not received
any treatment yet.
The subgroup consisted of 54 patients. Mean age was
62 ± 7 years, and the overall prevalence of NCEP ATP III-

MetS was 63% (34 of 54 patients), while the prevalence of
WHO-MetS was 42.5% (23 of 54 patients).
Age, height, weight, BMI, waist circumference, hip
circumference, waist/hip circumference ratio, fasting
blood glucose levels, HDL levels, TG levels, HbA1c
level HOMA index, and frequency of insulin resistance,
all were found to be similar between JSN-dominant and
O-dominant subgroups (Table 2). The prevalence of NCEP
ATP III-MetS was statistically higher in the JSN-Domaiant
subgroup compared to the O-dominant subgroup [22
(75.9%) vs 12 (48%) respectively, p = 0.03]. The prevalence
of WHO-MetS was also statistically higher in the JSNdominant subgroup compared to the O-dominant
subgroup [16 (55%) vs 6 (24%) respectively, p = 0.02].
Logistic regression analysis for the subgroup showed that
the presence of NCEP ATP III-MetS was an independent
risk factor for JSN-dominant knee OA phenotype [OR
and 95% CI = 3.41 (1.07–10.83) and p = 0.04]. When BMI
was taken into account in risk factor analysis, it was found
that significance was not lost [OR and 95% CI = 3.48 (1.09
–11.13) and p = 0.04] (Table 3). Similarly, the presence of
WHO-MetS was found to be a significant risk factor for
JSN-dominant knee OA phenotype [OR and 95% CI =
3.97 (1.22–12.96) and p = 0.02]. Likewise, it was found
that the result did not change when BMI was taken into
account in the risk factor analysis [OR and 95% CI = 4.07
(1.24– 13.44) and p = 0.02] (Table 3).
4. Discussion
In the present study, the prevalence of MetS in the
patients with knee OA was 79% in the main group using
NCEP ATP III-MetS criteria and 65% using WHO-MetS
criteria. The prevalence rates of MetS for the subgroup
with no past medical history of Type 2 DM, were 63% and
42.5%, respectively. According to the TEKHARF study
data conducted in our country, the prevalence of MetS in
the general population was reported to be 54.5% in women
aged 40 and over [10]. Therefore, our results suggest that, in
patients with knee OA, regardless of the criteria used, the
prevalence of MetS is higher than the general population.
Metabolic syndrome and knee OA are two important
public health problems with similar risk factors, similar
pathogenetic mechanisms, and high prevalence. Many
studies have been conducted on the relationship between
knee OA and MetS to date. These studies contain
conflicting results. In a recently published metaanalysis,
Xie et al. found that the presence of MetS is an independent
risk factor for radiographic knee OA [13]. However,
some large-scale studies, including the Framingham OA
study and the Chingford cohort, reported that there is a
significant relationship between MetS and knee OA, but this
relationship disappears when body weight or BMI factors
are taken into account [6,14-18]. In the present study, we
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Table 1. Demographical, anthropometrical, and biochemical parameters of the study
population.
Mean ± SD

JSN-dominant
(n:50)

O-dominant
(n:50)

p

Age (years)

61 ± 7

63 ± 5

0.17

Height (m)

160 ± 4

159 ± 5

0.62

Weight (kg)

88 ± 12

89 ± 12

0.79

BMI (kg/m²)

35 ± 5

35 ± 5

0.97

Waist circumference (cm)

116 ± 10

115 ± 11

0.61

Hip circumference (cm)

126 ± 12

126 ± 12

0.92

Waist / hip ratio

0.93 ± 0.1

0.92 ± 0.1

0.54

Fasting glucose (mg/dL)

126 ± 54

120 ± 44

0.55

HDL (mg/dL)

50 ± 13

51 ± 11

0.81

TG (mg/dL)

167 ± 105

161 ± 96

0.77

BMI: body mass index, HDL: high-density lipoprotein, TG: triglyceride.
Table 2. Demographical, anthropometrical, and biochemical parameters in the subgroup with
no past medical history of type 2 DM.
JSN-dominant
(n:29)

O-dominant
(n:25)

p

Age (years)

62 ± 8

62 ± 5

0.64

Height (m)

160 ± 4

159 ± 4

0.56

Weight (kg)

86 ± 12

86 ± 13

0.95

BMI (kg/m²)

34 ± 5

34 ± 5

0.81

Waist circumference (cm)

113 ± 11

112 ± 10

0.66

Hip circumference (cm)

126 ± 11

126 ± 11

0.69

Waist/ hip ratio

0,90 ± 0,08

0,89 ± 0,1

0.36

Fasting glucose (mg/dL)

96 ± 12

96 ± 9

0.86

HbA1c

4,9 ± 0.3

5 ± 0,3

0.53

HDL (mg/dL)

53 ± 15

52 ± 10

0.77

TG (mg/dL)

139 ± 61

128 ± 51

0.48

HOMA

3,3 ± 1,9

2,7 ± 1,4

0.20

Insulin resistance [n (%)]

15 (52%)

7 (28%)

0.08

Unless otherwise stated, data are presented as mean ± SD. BMI: body mass index, HbA1c:
Hemoglobin A1c, HDL: high-density lipoprotein, TG: triglyceride, HOMA: homeostasis model
of assessment, DM: diabetes mellitus.

hypothesized that the development of osteophyte and
JSN could be due to different pathogenetic mechanisms,
and hence, we categorized patients with knee OA
concerning the radiographic phenotypes, JSN-dominant
vs O-Dominant. Although MetS tended to be more
frequent in the JSN-dominant phenotype, the difference
did not reach statistical significance. However, in the
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subgroup analyses, in which we excluded those with a past
medical history of type 2 DM, we demonstrated that the
prevalences of NCEP ATP III-MetS and WHO-MetS were
statistically higher in the JSN-dominant group compared
to the O-dominant group. Moreover, in this subgroup, we
determined that the presence of MetS is an independent
risk factor for the development of JSN-dominant knee OA
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Table 3. Results of logistic regression analysis for the JSN-dominant knee OA phenotype in subgroup
patients.
NCEP ATP III

WHO

OR

95% CI

p

OR

95% CI

p

Age

0.98

0.89–1.07

0.60

0.98

0.89–1.07

0.65

BMI

1.01

0.89–1.14

0.90

1.02

0.90–1.16

0.71

MetS

3.48

1.09–11.13

0.04

4.07

1.24–13.44

0.02

NCEP ATP III: National Cholesterol Education Program Adult Treatment Panel III, WHO: World Health
Organization, BMI: body mass index, MetS: metabolic syndrome.

phenotype and we found that this effect is independent of
BMI. As is known, obesity is an important risk factor for
the development of knee OA. In many publications on the
pathogenesis of knee OA, obesity is an independent risk
factor, especially for osteophyte development [7,19,20]. In
another study we conducted using the same methodology,
involving 734 female patients aged 40 and over, we
found that the presence of obesity increased the risk of
O-dominant knee OA phenotype 7.17 times [7]. In the
pathogenesis of knee OA, JSN occurs primarily as a result of
cartilage loss. In another study supporting these findings,
Pan et al. followed 435 patients for 10.7 years and found
that the cartilage volume loss observed in the medial tibial
plateau was significantly higher in individuals with MetS
than in individuals without MetS on magnetic resonance
imaging [21]. Therefore, all of these findings suggest that
MetS, but not obesity per se, is a significant risk factor
for the development of knee OA with JSN dominant
phenotype. In addition, we could hypothesize that the
Kellgren and Lawrence (K-L) radiographic staging system
used in the previous studies might have led to conclusions
suggesting that the relationship between MetS and knee
OA was mostly related to obesity since the presence of a
definite osteophyte is required for radiographic OA in this
system [22]. Hence, this staging system might have led to

the exclusion of those with JSN-dominant phenotype from
these studies. Therefore, in the present study, in addition
to the ACR clinical and radiographic classification criteria
for knee OA, we graded the osteophytes and degree of JSN
using the revised OARSI atlas [9]. Moreover, unlike most
previous studies we used two different sets of criteria for
MetS analyses, strengthening the reliability of the results
of the present study.
There are limitations of our study. We think that the
major limitation is the inclusion of patients with a past
medical history of type 2 DM since they were on medical
therapy which might have modified their MetS status.
It is also possible that inflammatory pathways that may
be playing roles in the development of knee OA might
have been also affected by these medications. This might
have failed to detect any difference when diabetics under
treatment were included in analyses.
In conclusion, our results suggest that the development
of osteophyte and JSN, which are two important
components of the radiography in knee OA, might have
different pathogenetic mechanisms. Our results also
suggest that MetS is an independent risk factor for the
development of JSN-dominant phenotype, rather than the
O-dominant phenotype, in knee OA patients with no past
medical history of DM.
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